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Background: Despite the increasing popularity of Icelandic horses, published reference intervals (RIs) in this breed
are rare. Due to their isolation and their small gene pool, alterations in some variables are likely and some possible
breed-specific peculiarities have been described. The purpose of the present study was the establishment of
comprehensive RIs in Icelandic horses according to recently published guidelines.
In a prospective observational study, blood samples were collected from the jugular vein of 142 Icelandic
horses into EDTA and serum tubes. Reference intervals were established for haematologic and biochemical
analytes on the Advia 2120i™ and the Dimension ExL™ by established methods. RIs were defined as central
95 % intervals bounded by the 2.5th and 97.5th percentiles with their 90 % confidence intervals, calculated
according to recently published ASVCP guidelines. An inhouse-developed quality control system using observed total
allowable error was used for the surveillance of the internal quality control preceding the measurements.
Results: The RIs were as follows: haematocrit: 0.29–0.39, RBC: 5.79–8.63 T/l, haemoglobin: 102.0–142.3 g/l, MCV: 42–51 fl,
platelets: 146–263 G/l, WBC: 4.13–8.57 G/l, segs: 1.98–4.73 G/l, lymphocytes: 1.25–3.49 G/l, monocytes: 0.06–0.31 G/l,
eosinophils: 0.04–0.50 G/l, glucose: 4.0–5.7 mmol/l, urea: 3.2–6.4 mmol/l, creatinine: 79.6–141.4 μmol/l, total
protein: 54.4–72.9 g/l, albumin: 27.7–36.8 g/l, total bilirubin: 8.1–21.1 μmol/l, triglycerides: 0.03–0.44 mmol/l,
cholesterol: 1.75–2.90 mmol/l, ALP: 1.35–3.55 μkat/l, AST: 4.52–8.80 μkat/l, GLDH: 0.0–0.18 μkat/l, GGT: 0.11–0.39
μkat/l, CK: 2.53–6.52 μkat/l, LDH: 3.32–7.95 μkat/l, iron: 16.4–39.9 μmol/l, calcium: 2.69–3.19 mmol/l, phosphate:
0.5–1.3 mmol/l, magnesium: 0.6–0.9 mmol/l, sodium: 134–141 mmol/l, potassium: 3.6–4.7 mmol/l, chloride:
100–105 mmol/l.
Conclusions: Reference intervals of several haematologic and biochemical analytes differed from the transferred
historical reference intervals applied to equine samples in the authors’ laboratory. These might be of clinical importance
in some analytes such as creatine kinase.
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Table 1 Analytical methods used on the ADVIA 2120i
Analyte Unit Method TEo (TEa) (%)
Haematocrit (Hct) l/l Calculated from Hct, MCV 3.7 (10)
Erythrocytes (RBC) T/l Light scatter 2.1 (10)
Haemoglobin (Hb) g/l Cyanide-free colorimetric
method
1.9 (10)
MCV fl Light scatter/calculated 1.9 (7)
MCH pg Calculated NA
MCHC g/l Light scatter/calculated 5.0 (7)
CH g/l Light scatter/calculated NA
CHCM g/l Light scatter/calculated NA
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Icelandic horses are small, long-living and robust. The
average height at withers of the modern type is 136.4 cm
(13.4 hands), established by video-morphometry [1].
They were bred completely isolated from other horse
breeds for about a millennium and even today horses
that have left Iceland are legally prevented from returning
[2]. During the last four decades Icelandic horses have be-
come increasingly popular as leisure and competition
horses in many countries. The Icelandic horse studbook,
‘WorldFengur’, recorded more than 240,000 living Ice-
landic horses by October 2013 [3]. Intense selective pres-
sures applied over time have resulted in substantial
variation among horse breeds [4]. Statistically significant
alterations of several haematologic and biochemical ana-
lytes have been described [5–7] and, therefore, divergent
breed-related reference intervals (RIs) are to be expected
[8, 9]. For example, Icelandic horses reportedly have
the lowest number of monocytes of all horse breeds
(1.7–5.4 % or 0.10–0.45 G/l) according to a recent study
performed on the ADVIA 2120i haematology analyser [5].
Some studies found muscle enzyme activities that were
significantly higher than in the general horse population
[5, 10].
Unkel calculated RIs for a number of biochemical ana-
lytes for Icelandic horses. The RIs, however, were based
upon a 16–84 % interval which makes a comparison
with more recently generated 95 % population-based RIs
difficult [11–13].
Recently breed-specific RIs have been established for
three different horse breeds using the same haematology
analyser (ADVIA) and a different chemistry analyser [5].
The purpose of the present study was to establish RIs
specific for Icelandic horses that might be useful in improv-
ing the interpretation of laboratory test results. Compre-
hensive RIs for horses, regardless of breed, are rarely found
in the peer-reviewed literature. The RIs were established by
following the recently published guidelines of the American
Society for Veterinary Clinical Pathology (ASVCP) [14, 15]
with regards to the selection of the reference population,
pre-analytical conditions, quality control, analytical condi-
tions and statistical methods.RDW % Light scatter/calculated NA
Platelets (PLT) G/l Light scatter 11.1 (25)
MPV fl Light scatter NA
WBC G/l MP stain, light scatter 10.2 (15)





G/l Light scatter All within
limits
CH cellular haemoglobin, CHCM corpuscular haemoglobin concentration, Hct
haematocrit, MCH mean cellular haemoglobin, MCHC mean cellular haemoglobin
concentration, MCV: mean cellular volume, MP myeloperoxidase, MPXI
myeloperoxidase index, NU no unit, NA not applicable, TEa total allowable
error, TEo total observed error, RDW red blood cell distribution widthMethods
Study population
The study population was recruited from 4 stables in
eastern Austria. All Icelandic horses were registered in
Worldfengur database (www.Worldfengur.com). They were
kept in paddocks year around with free access to shelter in
a covered area. Only horses of 3 years or more were se-
lected as Islandic horses are typically introduced into riding
stables at an age of 3 years. In addition the following a
priori inclusion criteria were chosen: resident in Austria formore than 6 month, no gestation or lactation, and the
absence of excessive exercise the day before the blood
sampling. Clinical examination was based on visual
examination, auscultation of the chest and heart and the
body temperature. Blood was collected from 141 horses.
The study was approved by the Ethics Commission of
the University of Veterinary Medicine, Vienna, Austria (li-
cense number 19/04/97/2013). The blood samples were
taken with the owners’ informed consent.Specimen collection
Blood was collected for 2 days in February 2013 between
9:00 and 12:00 a.m., within 3 to 6 h after the morning
feed. The left jugular vein was punctured by a 20 G
hypodermic needle and blood was allowed to flow freely
along the vessel wall into the vial up to the filling mark.
Blood for the complete blood counts was collected
into 4 ml EDTA-K3 tubes (Vacuette, Greiner bio-one,
Kremsmünster, Austria). Blood for biochemical ana-
lysis was collected into 10 ml serum tubes with a clot
activator and separator gel (Vacuette, Greiner bio-one,
Kremsmünster, Austria). Blood was allowed to clot for
30 min at room temperature and then spun down for
10 min at 4200 RPM (3800 × g, Universal 16, Hettich,
Tuttlingen, Germany).
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All samples were analysed within 6 h of sampling.
The EDTA-samples were analysed on an ADVIA
2120i™ (Siemens Healthcare Diagnostics, Vienna, Austria)
with the multi-species software (version 5.3.1.-MS). The
ADVIA™ system has recently been evaluated for the use in
horses [16].
Three levels of quality control materials provided by the
manufacturer (ADVIA® 3 in 1 TESTpointTM Hematology-
Controls, Siemens Healthcare Diagnostics Inc., Tarrytown,
NY, USA) were analysed daily according to the lab’s work-
ing instructions. The units, methods used and the total
observed error (TEo) are shown in Table 1. The TEo
was compared to the total allowable error (TEa) [17]
to determine whether the assay performance was satis-
factory [18].
The RIs and the confidence intervals (CIs) were also











Alkaline phosphatase (ALP) μkat/l (IU/l)
Aspartate aminotransferase (AST) μkat/l (IU/l)
Alanine aminotransferase (ALT) μkat/l (IU/l)
Glutamate hydrogenase (GLDH) μkat/l (IU/l)
γ-glutamyl transferase (GGT) μkat/l (IU/l)
Lipase μkat/l (IU/l)
Creatine kinase (CK) μkat/l (IU/l)








The TEo in bold indicates that the value exceeded the ASVCP-recommended TEa du
DGKG Deutsche Gesellschaft für klinische Chemie, DGGR 1,2-o-dilauryl-rac-glycero gluta
for clinical chemistry, ISE ion selective electrode, PDG pyruvate dehydrogenase, TEa: todirectly measured cellular haemoglobin (CH), directly
measured mean corpuscular haemoglobin concentration
(CHCM) and myeloperoxidase index (MPXI). In addition,
RIs were also established for the Hct/Hb ratio.Biochemical QC and analysis
All samples were analysed within 6 h of sampling.
The serum samples were analysed on the fully selective
wet chemistry analyser Dimension ExL™ (Siemens Health-
care Diagnostics, Vienna, Austria). Two levels of quality
control material (Liquid Assayed Multiqual®, Bio-Rad
Laboratories, Irvine, CA, USA, Cat. No. 694, 695) were ana-
lysed daily prior to running the samples. The units,
methods and observed total error (TEo) results compared
with the TEa are shown in Table 3 [19]. The reagents were
ExL-specific (Siemens Healthcare Diagnostics, Vienna,
Austria), with the exception of albumin and GLDH (LaborMethod TEo (TEa) (%)
hexokinase-G6-PDG 5.0 (20)
enzymatic-kinetic UV-test with urease 13.1 (15)
picric acid 13.3 (20)
biuret 9.9 (10)
bromocresol green 10.8 (15)
diazo-sulfaniline acid 11.1 (30)
diazo-sulfaniline acid/HCl 37.3 (35)
4-step, enzymatic 10.2 (25)
cholesterol esterase/cholesterol oxidase 6.6 (20)
IFCC, kinetic 18.9 (25)
IFCC, with pyridoxale-phosphate activation 9.1 (30)
IFCC, with pyridoxale phosphate activation 23.0 (25)
DGKC, optimised 45.1 (30)
IFCC, kinetic 21.9 (20)
DGGR 24.5 (25)
IFCC, kinetic 7.1 (30)
IFCC, kinetic 8.7 (20)
Ferene 6.3 (30)
α-cresolpthaleine 7.5 (10)
phosphate-molybtate, modified 10.2 (15)




ring the period of analysis
ric; acid-(6′-methylresorufin), HCl hydrochloric acid, IFCC international federation
tal allowable error, TEo total observed error
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at 37 °C.
The units, methods used and the total observed error
(TEo) are shown in Table 2.
Statistics
The reference intervals were calculated following the
ASVCP guidelines [14]. Normality was assessed by the
Anderson-Darling test. Outliers were identified by Tukey
and Dixon-Reed methods and were eliminated after
visual inspection. Data analysis was performed by MS
Excel (Microsoft, Redmond, WA, USA) with the
macro-instruction set Reference Value Adviser v1.3 (Ecole
Nationale Vétérinaire, Toulouse, France) according to
published guidelines [20]. Depending on the distribution,Table 3 Reference limits and their CIs for haematology analytes; n i
















Segs (%) 138 37.8–67.7
Segs (abs) 136 1.98–4.73
Lymphocytes (%) 136 25.7–52.1
Lymphocytes (abs) 132 1.25–3.49
Monocytes (%) 137 1.2–4.4
Monocytes (abs) 136 0.06–0.31
Eosinophils (%) 124 0.7–7.6
Eosinophils (abs) 123 0.04–0.50
Basophils (%) 139 0.1–1.0
Basophils (abs) 138 0.01–0.07
Large unstained cells (%) 139 0.1–0.5
Large unstained cells (abs) 138 0.00–0.03
MPXI 138 1.3–17.2
Bold: ratio exceeded the desired maximum ratio (<0.2)
CH cellular haemoglobin, CHCM corpuscular haemoglobin concentration, CI(s) confi
MCH mean cellular haemoglobin, MCHC mean cellular haemoglobin concentration,
PLT platelets, RBC red blood cells, RDW red blood cell distribution width, RI(s) referethe parametric or robust method with or without Box-
Cox transformation was applied to calculate the 95 %
population-based RIs.
Descriptive statistics were calculated by Analyze-It
for MS Excel (Analyze-It Software Ltd, Leeds, UK).
Following the recommendations by the Clinical Labora-
tory Standards Institute (CLSI) and the International Fed-
eration for Clinical Chemistry (IFCC) [21], CI should not
exceed 0.2 times (or 1/5) the width of the RI (WCI/WRI
<0.2, where WCI is the width of the CI and WRI is the
width of the RI).
Results
The median age of the reference animals was 13.7 years,
the mean age 13.0 years and maximum age of 27 years.ndicates the number of reference individuals after the removal







0.29–0.29 0.38–0.40 0.0 / 0.2
5.48–5.98 8.46–8.68 0.2 / 0.1
100.0–103.0 137.0–145.0 0.1 / 0.2
2.69–2.74 2.87–2.89 0.3 / 0.1
346.0–349.0 364.0–369.0 0.2 / 0.3
14.4–15.0 18.0–18.8 0.2 / 0.2
41–43 50–52 0.2 / 0.2
148.0–155.0 181.0–187.0 0.2 / 0.2
348.0–352.0 374.0–381.0 0.2 / 0.2
16.3–16.9 19.1–19.8 0.2 / 0.3
3.63–4.23 8.20–8.83 0.1 / 0.1
140–156 256–282 0.1 / 0.2
6.1–6.3 10.0–11.3 0.0 / 0.3
34.8–41.4 64.9–69.6 0.2 / 0.2
1.83–2.28 4.55–4.90 0.2 / 0.1
21.4–27.4 50.9–54.2 0.2 / 0.1
1.01–1.40 3.19–3.70 0.2 / 0.2
0.7–1.5 4.0–4.9 0.2 / 0.2
0.05–0.07 0.27–0.37 0.1 / 0.4
0.5–1.1 7.4–8.1 0.1 / 0.2
0.03–0.07 0.48–0.52 0.1 / 0.1
0.1–0.2 0.8–1.1 0.1 / 0.3
0.00–0.01 0.05–0.08 0.1 / 0.4
0.0–0.1 0.4–0.6 0.3 / 0.5
0.00–0.01 0.03–0.04 0.2 / 0.3
0.6–2.4 16.0–18.5 0.1 / 0.2
dence interval(s), Hb haemoglobin, Hct haematocrit, LRL lower reverence limit,
MPV mean platelet volume, MP myeloperoxidase, MPXI myeloperoxidase index,
nce interval(s), URL upper reference limit, WBC white blood cells
Fig. 1 Comparison of the haematology RIs generally used for horses in the authors’ laboratory with the RIs established for Icelandic horses
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stallions. Two horses were excluded from the beginning
due to elevated liver parameters.Haematology results
All haematology analytes were calculated by the non-
parametric method, because the required number of
reference individuals (n ≥120) was achieved. A normal
distribution was observed with the following analytes: RBC,
MCHC, MCH, RDW, MPV, Hct/Hb, and lymphocytes %.
Results and their CIs are summarised in Table 3. In Fig. 1
the calculated RIs are compared to the haematology RIs
used for horses in the author’s lab.Biochemistry results
The RIs and the 90 % CI of the upper and lower RL for all
biochemical analytes except potassium were calculated by
the non-parametric method, because the required number
of reference individuals (n >120) was achieved. Potassium
(n = 109) was calculated by the parametric method after
Box-Cox transformation due to the large number of out-
liers which were excluded. The CIs were calculated by
bootstrap. A normal distribution was observed with the
following analytes: total protein, albumin, total bilirubin,
triglycerides, cholesterol, AST, iron and calcium. The bio-
chemistry RIs and their CIs are summarised in Table 4. In
Fig. 2 the calculated RIs are compared to biochemistry
RIs used for horses in the author’s lab.
Table 4 Reference limits and their confidence intervals for biochemical analytes; n indicates the number of reference individuals











Glucose 135 4.0–5.7 3.9–4.1 5.5–5.8 0.1 / 0.2
Urea 139 3.2–6.4 3.0–3.5 6.0–6.7 0.2 / 0.2
Creatinine 137 79.6–141.4 79.6–88.4 132.6–141.4 0.1 / 0.1
Total protein 138 54.4–72.9 53.1–55.5 71.4–75.1 0.1 / 0.2
Albumin 132 27.7–36.8 27.3–28.5 35.4–37.2 0.1 / 0.2
Bilirubin, total 132 8.1–21.1 7.5–9.7 20.2–22.4 0.2 / 0.2
Bilirubin, direct 136 2.7–5.5 2.6–2.9 5.1–5.6 0.1 / 0.1
Triglycerides 133 0.03–0.44 0.01–0.06 0.38–0.47 0.1 / 0.2
Cholesterol 136 1.75–2.90 1.68–1.81 2.77–3.00 0.1 / 0.2
ALP 135 1.35–3.55 1.28–1.52 3.45–3.67 0.1 / 0.1
(81–213) (77–91) (207–220)
AST 133 4.52–8.80 3.85–4.82 8.15–8.87 0.2 / 0.2
(271–528) (231–289) (489–532)
ALT 138 0.01–0.15 0.0–0.02 0.15–0.17 0.1 / 0.1
(0.5–9.0) (0.0–1.0) (9.0–10.0)
GLDH 132 0.0–0.18 0.0–0.002 0.16–0.19 0.0 / 0.2
(0.0–10.7) (0.0–0.1) (9.4–11.5)
GGT 127 0.11–0.39 0.06–0.14 0.36–0.40 0.2 / 0.1
(6.6–23.6) (3.3–8.2) (21.4–23,8)
Lipase 135 0.43–1.12 0.38–0.47 1.07–1.15 0.1 / 0.1
(26–67) (23–28) (64–69)
CK 134 2.53–6.52 2.28–2.72 5.92–6.57 0.1 / 0.2
(152–391) (137–163) (355–394)
LDH 136 3.32–7.95 2.80–3.70 7.65–8.17 0.2 / 0.1
(199–477) (168–222) (459–490)
Iron (Fe) 137 16.4–39.9 14.7–21.7 38.0–41.4 0.3 / 0.1
Calcium (Ca) 139 2.69–3.19 2.65–2.73 3.16–3.25 0.2 / 0.2
Phosphate (P) 139 0.5–1.3 0.4–0.6 1.3–1.5 0.3 / 0.3
Magnesium (Mg) 138 0.6–0.9 0.6–0.6 0.9–0.9 0.0 / 0.0
Sodium (Na) 138 134–141 134–135 140–141 0.2 / 0.2
Potassium (K) 109 3.6–4.7 3.5–3.6 4.6–4.8 0.1 / 0.2
Chloride (Cl) 133 100–105 100–100 105–105 0.0 / 0.0
Bold: ratio exceeded the desired maximum ratio (<0.2). Enzyme activities in brackets are in IU/l
ALT alanine aminotransferase, AP alkaline phosphatase, ASVCP american society for veterinary clinical pathology, AST aspartate aminotransferase, CK creatine
kinase, GGT γ-glutamyl transferase, GLDH glutamate hydrogenase, LDH lactate dehydrogenase, LRL lower reverence limit, RI(s) reference interval(s), URL upper reference limit
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The aim of this prospective study was to establish
comprehensive RIs with well characterised analytical
methods in a population of Icelandic horses with a well
defined health state and in accordance with recently pub-
lished guidelines [14, 15, 21]. Haematological and bio-
chemical RIs may vary with age, sex, and season [5, 22].However, data were not stratified in our study because
under the conditions the horses were kept, a homogenous
distribution for the variables mentioned above could not
be achieved. The horses were at least 3 years of age and
many more geldings were represented compared to mares.
However this is representative of the overall Icelandic
horse population in eastern Austria.
Fig. 2 Comparison of the biochemistry RIs generally used for horses in the authors’ laboratory with the RIs established for Icelandic horses
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Worldfengur, where of approximately 35 % were imported
from Iceland directly. It is also know from genetic studies
that very little variation was found between Icelandic
horses in different countries [23]. Therefore, the RI estab-
lished in our study most likely are also representative
for the Islandic horse population in general, despite the
under-representation of mares.
In addition to a reliable reference population, the quality
specifications for the methods are of paramount import-
ance for the reliability of the RIs [24], although QC data are
rarely included in reports of RI studies. In one recent study,
mean and coefficient of variation of analytes were presented
[25]. Friedrichs et al. recommended the recording of the
TEo for all methods [15]. In our study, all haematology ana-
lytes achieved the quality goals (Table 1). The TEo of a
given biochemistry analyte was compared to the TEa rec-
ommended by the ASVCP guidelines on total error and
was for most methods below the recommended limit [14].
The biochemical analytes direct bilirubin, potassium, and
GLDH did not meet the analytical goals. The deviations for
direct bilirubin and potassium were small; in the case of po-
tassium, the TEo deviation was caused by a single QC value
exceeding the 2 standard deviation range. The TEo for
GLDH requires a more detailed consideration: while a TEo
of 30 % is typical for many enzymes, at a TEo of 45 %, a
given value could be 45 % higher or lower than the true ac-
tivity. However GLDH is a reliable indicator of hepatocyte
damage, hence it was decided to include the RIs for GLDH,
because there are few reference intervals for this analyte in
the peer-reviewed literature. The RIs compared well to
other published values [5], and the CIs were reasonably
narrow. Another source for poor method performance of
these few analytes might be the instability of the QC-
material suspected in 1 level in this study due to trend for
decreasing values in results over time.
The most noticeable finding in the haematologic raw
data was the high number of outliers for the eosinophil
percentage. The Dixon and Turkey tests identified 15/
139 values as outliers. With two exceptions, all animals
with increased eosinophil proportions were from the
same riding stable. The reason for these outliers is not
known. All horses were clinical healthy and regularly
dewormed, but the increase could reflect a subclinical
parasitism or allergy [26]. In one study, increased eo-
sinophil numbers were found in horses kept outdoors
24 h a day [27].
To establish a diagnosis of eosinophilia as well as the
increase of other leukocyte fractions, only the absolute
numbers must be considered [28, Additional file 1]. The
relative numbers, however, are still widely used among
referral laboratories and clinicians [29]. They are applied
for manual differentials and for the analysers’s internal
quality control, and therefore reported in this study.The RIs for Hct/Hb was included because it proved
useful for the primary plausibility checks in our LIMS of
haemograms measured on the ADVIA. According to our
working instructions, a spun haematocrit is performed, if
the ratio exceeds the lower or upper RL (unpublished data).
Haematologic RIs on the ADVIA for Icelandic horses
were established in a previous study for 6 different horse
breeds, including 84 Icelandic horses and used similar
statistical methods [5]. While there was a good agree-
ment in the overall data, differences were found for the
following analytes: haematocrit, MCHC, MCV, WBC,
platelets, lymphocytes (absolute) and eosinophils (rela-
tive and absolute). For MCHC, much higher ranges were
found in that and another study [28] with reference in-
tervals of 40.8 to 44.1 and 35 to 42 g/l, respectively. The
reason for this is not clear. Our MCHC values compared
well to the directly measured CHCM values.
The MPXI seemed to be useful as additional inflamma-
tory parameter for the diagnosis of sepsis in horses [30],
but this could not be confirmed in another study [31].
This low monocyte count found by Gieseler, was con-
firmed by our data from the ADVIA differentials [5]. It
may, however, be caused by the way the ADVIA displays
the monocytes of Icelandic horses in the Perox channel,
rather than by a breed-associated peculiarity [32]. How-
ever, the routine gating is likely to be applied since the
manual gating, while not difficult, is time consuming.
Analysis of potassium data revealed 30/139 (21.6 %)
outliers, almost all of them from a single stable. The
eliminated values exceeded the RIs given elsewhere [5].
Most likely this was caused by a pre-analytical problem,
but a definitive reason for this finding was not identified.
Potassium is contained in high concentrations in the
equine RBCs, WBCs and PLT and can diffuse into serum
[33]. The room temperature in the preparation room
where the blood was left for clot formation could not be
tightly controlled. No serum sample was visibly haemo-
lysed, and no other analytes were affected.
In several publications, CK, AST and LDH activities
were increased in Icelandic horses compared to standard
and thoroughbred horses [10, 11, 34]. Other studies
showed no increase in liver- and muscle-specific en-
zymes in horses in Iceland or at 24 weeks following their
importation to Germany [35]. Our study provides sup-
port for elevated CK activity in Icelandic horses. The
upper reference limit in Icelandic horses (6.52 μkat/l, CI:
5.92–6.15) was approximately two times higher than for
the general horse populations and about three times
higher than that found for horses in general in one study
[6]. It compares well to several other studies [6, 10, 11].
It is, however, lower than the upper RL found by Gieseler
with the same method (11.14 μkat/l) [4]. The reasons for
these high CK activities are not clear, but an increased
muscle mass in relation to the body mass [36], different
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macroenzyme complexes that have a slower rate of elimin-
ation [38] could contribute to higher CK activities. Further
studies are needed to clarify the cause(s).
The calculation of CI of the RLs should be part of the
establishment of reference intervals [21]. CIs provide an
estimate of the uncertainty of the limits and are gener-
ally narrower for large samples sizes [14]. For the non-
parametric calculation of CI, at least 120 individuals are
required, if less are available, other methods like boot-
strap have to be used [14]. This was only necessary for
potassium in our study.
The width of the 90 % CIs calculated in this study, is
not described in detail in the ASVCP online guidelines, but
is described in the CLSI guidelines [21] and by Friedrichs
et al. [15]. The CI width exceeded 0.2 in 9/26 (34.6 %)
of haematology analytes for at least one RL. This oc-
curred most frequently with small fractions (differential
cell count percentages), where effective outlier treat-
ment was not possible. In other cases, the deviations
are small and sometimes could be caused by the round-
ing of the figures (MCV).
In 2/24 (8.3 %) of biochemistry analytes the CI width
exceeded the recommended value. In the case of phos-
phorus, both RLs, in the case of iron only the lower RL
was affected. This could have been caused by the round-
ing of the figures within the LIMS. To improve the CI
width and increase confidence in the validity of the ref-
erence interval, additional individuals could be added to
the analysis.
The results highlight the difficulties of comparing the
RIs generated in this study with other RIs published for
Icelandic horses and for other breeds. These compari-
sons were complicated by the use of different analytical
and statistical methods, as well as the different sizes and
composition of the reference populations. The recently
published guidelines for the establishment of RIs in vet-
erinary medicine were comprehensive and could be eas-
ily applied. Following them as closely as possible, will
facilitate the comparison of RIs in the future. Careful
scrutiny of the sources of RIs and the reference popula-
tion, collection conditions, analytical conditions and
statistical methods is needed to determine if they may be
suitable for transference validation and to determine if
references intervals may need to be generated de novo
for a particular breed and/or practice population.
Considering the tradition of veterinary laboratory test-
ing it is amazing that somewhat arbitrarily established
RI’s have been of clinical utility at all. Furthermore it is
not clear if breed specific partitioning of RIs will improve
clinical decisions and patient care as slight differences in
RIs may not alter the clinical interpretation and decision-
making process. Information on biologic variation that
may help determine the significance of changes in patientdata is scarce or absent for equine laboratory analytes.
Only through continued experience with and analysis of
data for breed-specific RIs will we be able to determine if
breed-specific RIs may provide for improved clinical care
for equine patients. The standardisation of the approach
to reference interval generation, in accordance with the
ASVCP guidelines, should help provide for a sound basis
for comparisons of reference intervals. It will require
time, however, for studies to be done using this stand-
ard approach.Additional file
Additional file 1: Figure S1. Additional material the example shows
the differentials of 2 animals, both with 92 % neutrophils (segs) and 8 %
lymphocytes. The first example with 4.0 G/l WBC results in an absolute
number of neutrophils WRI and a lymphopenia. In the second example
with 25.0 G/l WBC the result is a neutrophilia and an absolute number of
lymphocytes WRI.
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